Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Scientific Reports|June 11, 2016
Screening of saponins and sapogenins from Medicago species as potential PPARγ agonists and X-ray structure of the complex PPARγ/caulophyllogeninRoberta Montanari, Davide Capelli, Aldo Tava, et al.Scientific Reports|October 7, 2016
Structural basis for PPAR partial or full activation revealed by a novel ligand binding modeDavide Capelli, Carmen Cerchia, Roberta Montanari, et al.Biomolecules|May 16, 2023
Biological Screening and Crystallographic Studies of Hydroxy γ-Lactone Derivatives to Investigate PPARγ Phosphorylation InhibitionDavide Capelli, Giulia Cazzaniga, Matteo Mori, et al.Materials (Basel, Switzerland)|July 14, 2023
Electrochemical and Structural Characterization of Lanthanum-Doped Hydroxyapatite: A Promising Material for Sensing ApplicationsRocco Cancelliere, Giuseppina Rea, Laura Micheli, et al.International Journal of Molecular Sciences|February 18, 2017
Single-Nucleotide Polymorphism of PPARγ, a Protein at the Crossroads of Physiological and Pathological ProcessesMaria Petrosino, Laura Lori, Alessandra Pasquo, et al.Acta Crystallographica. Section D, Biological Crystallography|July 10, 2014
Structural basis of the transactivation deficiency of the human PPARγ F360L mutant associated with familial partial lipodystrophyClorinda Lori, Alessandra Pasquo, Roberta Montanari, et al.Scientific Reports|July 20, 2017
Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesisGloria Brusotti, Roberta Montanari, Davide Capelli, et al.Journal of Medicinal Chemistry|September 11, 2018
Identification of the First PPARα/γ Dual Agonist Able To Bind to Canonical and Alternative Sites of PPARγ and To Inhibit Its Cdk5-Mediated PhosphorylationAntonio Laghezza, Luca Piemontese, Carmen Cerchia, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|August 25, 2016
Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activityMarilena Tauro, Antonio Laghezza, Fulvio Loiodice, et al.Pharmaceuticals (Basel, Switzerland)|June 5, 2020
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal MalignancyAntonio Laghezza, Luca Piemontese, Leonardo Brunetti, et al.Pageof 3